Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lin

Showing results (701-710 of 792) with videos related to

Pageof 80
Sort By:
Oncogene|September 30, 2014
TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferationZ Mounir, F Lin, V G Lin, et al.
Cancer Biology & Therapy|October 16, 2009
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancerTae Jin Kim, Charles N Landen, Yvonne G Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Clinical and biological significance of vascular endothelial growth factor in endometrial cancerAparna A Kamat, William M Merritt, Donna Coffey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinomaChunhua Lu, Aparna A Kamat, Yvonne G Lin, et al.
Cancer Biology & Therapy|November 16, 2006
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancerCharles N Landen, William M Merritt, Lingegowda S Mangala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)Diane M Da Silva, Danielle M Enserro, Jyoti S Mayadev, et al.
Nature Metabolism|May 11, 2021
Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin statesKai-Chun Li, Enrico Girardi, Felix Kartnig, et al.
Cancer Research|January 11, 2007
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancerAparna A Kamat, Tae Jin Kim, Charles N Landen, et al.
Cancer Research|November 17, 2007
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinomaJyotsnabaran Halder, Yvonne G Lin, William M Merritt, et al.
American Journal of Human Genetics|June 19, 2001
A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneityC L Hsieh, I Oakley-Girvan, R R Balise, et al.
Pageof 80

Showing results (701-710 of 792) with videos related to

Sort By:
Pageof 80
Oncogene|September 30, 2014
TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferationZ Mounir, F Lin, V G Lin, et al.
Cancer Biology & Therapy|October 16, 2009
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancerTae Jin Kim, Charles N Landen, Yvonne G Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Clinical and biological significance of vascular endothelial growth factor in endometrial cancerAparna A Kamat, William M Merritt, Donna Coffey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinomaChunhua Lu, Aparna A Kamat, Yvonne G Lin, et al.
Cancer Biology & Therapy|November 16, 2006
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancerCharles N Landen, William M Merritt, Lingegowda S Mangala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)Diane M Da Silva, Danielle M Enserro, Jyoti S Mayadev, et al.
Nature Metabolism|May 11, 2021
Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin statesKai-Chun Li, Enrico Girardi, Felix Kartnig, et al.
Cancer Research|January 11, 2007
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancerAparna A Kamat, Tae Jin Kim, Charles N Landen, et al.
Cancer Research|November 17, 2007
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinomaJyotsnabaran Halder, Yvonne G Lin, William M Merritt, et al.
American Journal of Human Genetics|June 19, 2001
A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneityC L Hsieh, I Oakley-Girvan, R R Balise, et al.
Pageof 80